Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1965 4
1966 3
1967 3
1968 12
1969 6
1970 7
1971 2
1972 5
1974 1
1975 2
1976 6
1977 2
1978 5
1979 1
1980 1
1981 1
1982 3
1983 2
1984 2
1985 2
1986 1
1987 2
1988 1
1990 4
1992 1
1993 2
1995 2
1996 6
1997 1
1999 1
2001 2
2002 3
2004 1
2005 2
2006 1
2007 5
2008 8
2009 9
2010 5
2011 8
2012 8
2013 7
2014 5
2015 11
2016 12
2017 7
2018 7
2019 10
2020 7
2021 4
2022 7
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Ensemble method for dengue prediction.
Buczak AL, Baugher B, Moniz LJ, Bagley T, Babin SM, Guven E. Buczak AL, et al. Among authors: babin sm. PLoS One. 2018 Jan 3;13(1):e0189988. doi: 10.1371/journal.pone.0189988. eCollection 2018. PLoS One. 2018. PMID: 29298320 Free PMC article.
Safe medication compounding.
Golembiewski JA, Babin SF. Golembiewski JA, et al. Among authors: babin sf. J Perianesth Nurs. 2013 Apr;28(2):110-2. doi: 10.1016/j.jopan.2013.01.003. J Perianesth Nurs. 2013. PMID: 23522272 No abstract available.
All-fiber holmium distributed feedback laser at 2.07  μm.
Wolf AA, Skvortsov MI, Kamynin VA, Zhluktova IV, Abdullina SR, Dostovalov AV, Tsvetkov VB, Babin SA. Wolf AA, et al. Among authors: babin sa. Opt Lett. 2019 Aug 1;44(15):3781-3784. doi: 10.1364/OL.44.003781. Opt Lett. 2019. PMID: 31368967
223 results